FDA has approved the Valiant Navion thoracic stent graft system for the minimally invasive repair of descending thoracic aorta lesions from Medtronic plc. The system from the Dublin-based company is a new iteration of the prior Valiant Captivia thoracic stent graft system, which has been used on more than 100,000 patients globally. Read More
CLEVELAND – How are telemedicine and wearable technologies changing health care and how physicians see patients? That question was the focus of a panel that examined how such emerging technology can play a role in improving primary care. The panel took place during the Cleveland Clinic's 2018 Medical Innovation Summit and was part of the a series of discussions on how technologies, including digital health, are disrupting health care. Read More
